Low CD4 T-cell counts despite low levels of circulating HIV: Insights from the comparison of HIV-1 infected patients with a discordant response to antiretroviral therapy to patients with untreated advanced HIV-2 disease

Clinical Immunology

Volumn 125, Issue 1, 2007, Pages 67-75

  Albuquerque, Adriana S ^a   Foxall, Russell B ^a   Cortesão, Catarina S ^a   Soares, Rui S ^a   Doroana, Manuela ^b   Ribeiro, Alice ^b   Lucas, Margarida ^b   Antunes, Francisco ^b   Victorino, Rui M M ^a,b   Sousa, Ana E ^a  

^a INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^b HOSPITAL DE SANTA MARIA   (Portugal)

Author keywords

Antiretroviral therapy; HIV 2; HIV AIDS; IL 7; Immunological reconstitution; T cell activation

Indexed keywords

ANTIRETROVIRUS AGENT; CD27 ANTIGEN; CD4 ANTIGEN; CD45RA ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 7; PROTEIN BCL 2; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; ZIDOVUDINE;

ADULT; AGED; ARTICLE; CD4+ T LYMPHOCYTE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EXPOSURE; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TREATMENT RESPONSE; VIREMIA; VIRUS INHIBITION;

ADULT; AGED; AGED, 80 AND OVER; ANTI-RETROVIRAL AGENTS; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HIV INFECTIONS; HIV-1; HIV-2; HUMANS; INTERLEUKIN-7; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, INTERLEUKIN-7; VIREMIA;

EID: 34548488232     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2007.07.001     Document Type: Article

References (43)

1. Benveniste O., Flahault A., Rollot F., Elbim C., Estaquier J., Pedron B., Duval X., Dereuddre-Bosquet N., Clayette P., Sterkers G., Simon A., Ameisen J.C., and Leport C. Mechanisms involved in the low-level regeneration of CD4+ cells in HIV-1-infected patients receiving highly active antiretroviral therapy who have prolonged undetectable plasma viral loads. J. Infect. Dis. 191 (2005) 1670-1679
2. Marziali M., De Santis W., Carello R., Leti W., Esposito A., Isgro A., Fimiani C., Sirianni M.C., Mezzaroma I., and Aiuti F. T-cell homeostasis alteration in HIV-1 infected subjects with low CD4 T-cell count despite undetectable virus load during HAART. AIDS 20 (2006) 2033-2041
3. Aiuti F., and Mezzaroma I. Failure to reconstitute CD4+ T-cells despite suppression of HIV replication under HAART. AIDS Rev. 8 (2006) 88-97
4. Renaud M., Katlama C., Mallet A., Calvez V., Carcelain G., Tubiana R., Jouan M., Caumes E., Agut H., Bricaire F., Debre P., and Autran B. Determinants of paradoxical CD4 cell reconstitution after protease inhibitor-containing antiretroviral regimen. AIDS 13 (1999) 669-676
5. Kaufmann G.R., Bloch M., Finlayson R., Zaunders J., Smith D., and Cooper D.A. The extent of HIV-1-related immunodeficiency and age predict the long-term CD4 T lymphocyte response to potent antiretroviral therapy. AIDS 16 (2002) 359-367
6. Florence E., Lundgren J., Dreezen C., Fisher M., Kirk O., Blaxhult A., Panos G., Katlama C., Vella S., and Phillips A. Factors associated with a reduced CD4 lymphocyte count response to HAART despite full viral suppression in the EuroSIDA study. HIV Med. 4 (2003) 255-262
7. Goicoechea M., Smith D.M., Liu L., May S., Tenorio A.R., Ignacio C.C., Landay A., and Haubrich R. Determinants of CD4+ T cell recovery during suppressive antiretroviral therapy: association of immune activation, T cell maturation markers, and cellular HIV-1 DNA. J. Infect. Dis. 194 (2006) 29-37
8. Piketty C., Weiss L., Thomas F., Mohamed A.S., Belec L., and Kazatchkine M.D. Long-term clinical outcome of human immunodeficiency virus-infected patients with discordant immunologic and virologic responses to a protease inhibitor-containing regimen. J. Infect. Dis. 183 (2001) 1328-1335
9. Grabar S., Le Moing V., Goujard C., Leport C., Kazatchkine M.D., Costagliola D., and Weiss L. Clinical outcome of patients with HIV-1 infection according to immunologic and virologic response after 6 months of highly active antiretroviral therapy. Ann. Intern. Med. 133 (2000) 401-410
10. Sousa A.E., Carneiro J., Meier-Schellersheim M., Grossman Z., and Victorino R.M. CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load. J. Immunol. 169 (2002) 3400-3406
11. Jaffar S., Wilkins A., Ngom P.T., Sabally S., Corrah T., Bangali J.E., Rolfe M., and Whittle H.C. Rate of decline of percentage CD4+ cells is faster in HIV-1 than in HIV-2 infection. J. Acquir. Immune Defic. Syndr. Human Retrovirol. 16 (1997) 327-332
12. Marlink R., Kanki P., Thior I., Travers K., Eisen G., Siby T., Traore I., Hsieh C.C., Dia M.C., Gueye E.H., et al. Reduced rate of disease development after HIV-2 infection as compared to HIV-1. Science 265 (1994) 1587-1590
13. Berry N., Ariyoshi K., Jaffar S., Sabally S., Corrah T., Tedder R., and Whittle H. Low peripheral blood viral HIV-2 RNA in individuals with high CD4 percentage differentiates HIV-2 from HIV-1 infection. J. Hum. Virol. 1 (1998) 457-468
14. Popper S.J., Sarr A.D., Gueye-Ndiaye A., Mboup S., Essex M.E., and Kanki P.J. Low plasma human immunodeficiency virus type 2 viral load is independent of proviral load: low virus production in vivo. J. Virol. 74 (2000) 1554-1557
15. Soriano V., Gomes P., Heneine W., Holguin A., Doruana M., Antunes R., Mansinho K., Switzer W.M., Araujo C., Shanmugam V., Lourenco H., Gonzalez-Lahoz J., and Antunes F. Human immunodeficiency virus type 2 (HIV-2) in Portugal: clinical spectrum, circulating subtypes, virus isolation, and plasma viral load. J. Med. Virol. 61 (2000) 111-116
16. Damond F., Gueudin M., Pueyo S., Farfara I., Robertson D.L., Descamps D., Chene G., Matheron S., Campa P., Brun-Vezinet F., and Simon F. Plasma RNA viral load in human immunodeficiency virus type 2 subtype A and subtype B infections. J. Clin. Microbiol. 40 (2002) 3654-3659
17. Soares R., Foxall R., Albuquerque A., Cortesao C., Garcia M., Victorino R.M., and Sousa A.E. Increased frequency of circulating CCR5+ CD4+ T cells in human immunodeficiency virus type 2 infection. J. Virol. 80 (2006) 12425-12429
18. Macneil A., Sarr A.D., Sankale J.L., Meloni S.T., Mboup S., and Kanki P. Direct evidence of lower viral replication rates in vivo in HIV-2 infection than in HIV-1 infection. J. Virol. (2007) 5325-5330
19. Simon F., Matheron S., Tamalet C., Loussert-Ajaka I., Bartczak S., Pepin J.M., Dhiver C., Gamba E., Elbim C., Gastaut J.A., et al. Cellular and plasma viral load in patients infected with HIV-2. AIDS 7 (1993) 1411-1417
20. Kanki P.J., Travers K.U., S M.B., Hsieh C.C., Marlink R.G., Gueye N.A., Siby T., Thior I., Hernandez-Avila M., Sankale J.L., et al. Slower heterosexual spread of HIV-2 than HIV-1. Lancet 343 (1994) 943-946
21. O'Donovan D., Ariyoshi K., Milligan P., Ota M., Yamuah L., Sarge-Njie R., and Whittle H. Maternal plasma viral RNA levels determine marked differences in mother-to-child transmission rates of HIV-1 and HIV-2 in The Gambia. MRC/Gambia Government/University College London Medical School working group on mother-child transmission of HIV. AIDS 14 (2000) 441-448
22. Sousa A.E., Chaves A.F., Loureiro A., and Victorino R.M. Comparison of the frequency of interleukin-2, interferon-g and interleukin-4 producing T cells in two diseases with distinct clinical outcomes: the human immunodeficiency virus type 1 and 2 infections. J. Infect. Dis. 184 (2001) 552-559
23. Albuquerque A.S., Cortesao C.S., Foxall R.B., Soares R.S., Victorino R.M., and Sousa A.E. Rate of increase in Circulating IL-7 and loss of IL-7R{alpha} expression differ in HIV-1 and HIV-2 infections: two lymphopenic diseases with similar hyperimmune activation but distinct outcomes. J. Immunol. 178 (2007) 3252-3259
24. Champagne P., Ogg G.S., King A.S., Knabenhans C., Ellefsen K., Nobile M., Appay V., Rizzardi G.P., Fleury S., Lipp M., Forster R., Rowland-Jones S., Sekaly R.P., McMichael A.J., and Pantaleo G. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 410 (2001) 106-111
25. Ariyoshi K., Berry N., Wilkins A., Ricard D., Aaby P., Naucler A., Ngom P.T., Jobe O., Jaffar S., Dias F., Tedder R.S., and Whittle H. A community-based study of human immunodeficiency virus type 2 provirus load in rural village in West Africa. J. Infect. Dis. 173 (1996) 245-248
26. Gomes P., Taveira N.C., Pereira J.M., Antunes F., Ferreira M.O., and Lourenco M.H. Quantitation of human immunodeficiency virus type 2 DNA in peripheral blood mononuclear cells by using a quantitative-competitive PCR assay. J. Clin. Microbiol. 37 (1999) 453-456
27. Vitone F., Gibellini D., Schiavone P., and Re M.C. Quantitative DNA proviral detection in HIV-1 patients treated with antiretroviral therapy. J. Clin. Virol. 33 (2005) 194-200
28. Fry T.J., and Mackall C.L. The many faces of IL-7: from lymphopoiesis to peripheral T cell maintenance. J. Immunol. 174 (2005) 6571-6576
29. Napolitano L.A., Grant R.M., Deeks S.G., Schmidt D., De Rosa S.C., Herzenberg L.A., Herndier B.G., Andersson J., and McCune J.M. Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasis. Nat. Med. 7 (2001) 73-79
30. Llano A., Barretina J., Gutierrez A., Blanco J., Cabrera C., Clotet B., and Este J.A. Interleukin-7 in plasma correlates with CD4 T-cell depletion and may be associated with emergence of syncytium-inducing variants in human immunodeficiency virus type 1-positive individuals. J. Virol. 75 (2001) 10319-10325
31. Mazzucchelli R., and Durum S.K. Interleukin-7 receptor expression: intelligent design. Nat. Rev., Immunol. 7 (2007) 144-154
32. Schluns K.S., Kieper W.C., Jameson S.C., and Lefrancois L. Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nat. Immunol. 1 (2000) 426-432
33. Grossman Z., Meier-Schellersheim M., Sousa A.E., Victorino R.M., and Paul W.E. CD4+ T-cell depletion in HIV infection: are we closer to understanding the cause?. Nat. Med. 8 (2002) 319-323
34. Hazenberg M.D., Otto S.A., van Benthem B.H., Roos M.T., Coutinho R.A., Lange J.M., Hamann D., Prins M., and Miedema F. Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS 17 (2003) 1881-1888
35. Deeks S.G., Kitchen C.M., Liu L., Guo H., Gascon R., Narvaez A.B., Hunt P., Martin J.N., Kahn J.O., Levy J., McGrath M.S., and Hecht F.M. Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. Blood 104 (2004) 942-947
36. Hunt P.W., Martin J.N., Sinclair E., Bredt B., Hagos E., Lampiris H., and Deeks S.G. T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy. J. Infect. Dis. 187 (2003) 1534-1543
37. Giorgi J.V., Liu Z., Hultin L.E., Cumberland W.G., Hennessey K., and Detels R. Elevated levels of CD38+ CD8+ T cells in HIV infection add to the prognostic value of low CD4+ T cell levels: results of 6 years of follow-up. The Los Angeles Center, Multicenter AIDS Cohort Study. J. Acquir. Immune Defic. Syndr. 6 (1993) 904-912
38. Giorgi J.V., Ho H.N., Hirji K., Chou C.C., Hultin L.E., O'Rourke S., Park L., Margolick J.B., Ferbas J., and Phair J.P. CD8+ lymphocyte activation at human immunodeficiency virus type 1 seroconversion: development of HLA-DR+ CD38- CD8+ cells is associated with subsequent stable CD4+ cell levels. The Multicenter AIDS Cohort Study Group. J. Infect. Dis. 170 (1994) 775-781
39. Roederer M., Dubs J.G., Anderson M.T., Raju P.A., and Herzenberg L.A. CD8 naive T cell counts decrease progressively in HIV-infected adults. J. Clin. Invest. 95 (1995) 2061-2066
40. Torti C., Cologni G., Uccelli M.C., Quiros-Roldan E., Imberti L., Airo P., Pirovano S., Patroni A., Tirelli V., and Carosi G. Immune correlates of virological response in HIV-positive patients after highly active antiretroviral therapy (HAART). Viral. Immunol. 17 (2004) 279-286
41. Marchetti G., Gori A., Casabianca A., Magnani M., Franzetti F., Clerici M., Perno C.F., Monforte A., Galli M., and Meroni L. Comparative analysis of T-cell turnover and homeostatic parameters in HIV-infected patients with discordant immune-virological responses to HAART. AIDS 20 (2006) 1727-1736
42. Andersson J., Fehniger T.E., Patterson B.K., Pottage J., Agnoli M., Jones P., Behbahani H., and Landay A. Early reduction of immune activation in lymphoid tissue following highly active HIV therapy. AIDS 12 (1998) F123-F129
43. Sloand E.M., Kumar P.N., Kim S., Chaudhuri A., Weichold F.F., and Young N.S. Human immunodeficiency virus type 1 protease inhibitor modulates activation of peripheral blood CD4(+) T cells and decreases their susceptibility to apoptosis in vitro and in vivo. Blood 94 (1999) 1021-1027